1. Home
  2. CDMO vs AIO Comparison

CDMO vs AIO Comparison

Compare CDMO & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDMO
  • AIO
  • Stock Information
  • Founded
  • CDMO 1981
  • AIO 2019
  • Country
  • CDMO United States
  • AIO United States
  • Employees
  • CDMO N/A
  • AIO N/A
  • Industry
  • CDMO Biotechnology: Pharmaceutical Preparations
  • AIO Finance/Investors Services
  • Sector
  • CDMO Health Care
  • AIO Finance
  • Exchange
  • CDMO Nasdaq
  • AIO Nasdaq
  • Market Cap
  • CDMO 784.1M
  • AIO 760.3M
  • IPO Year
  • CDMO N/A
  • AIO N/A
  • Fundamental
  • Price
  • CDMO $12.15
  • AIO $22.46
  • Analyst Decision
  • CDMO Buy
  • AIO
  • Analyst Count
  • CDMO 5
  • AIO 0
  • Target Price
  • CDMO $13.63
  • AIO N/A
  • AVG Volume (30 Days)
  • CDMO 3.6M
  • AIO 141.5K
  • Earning Date
  • CDMO 12-05-2024
  • AIO 01-01-0001
  • Dividend Yield
  • CDMO N/A
  • AIO 9.05%
  • EPS Growth
  • CDMO N/A
  • AIO N/A
  • EPS
  • CDMO N/A
  • AIO N/A
  • Revenue
  • CDMO $142,358,000.00
  • AIO N/A
  • Revenue This Year
  • CDMO $19.31
  • AIO N/A
  • Revenue Next Year
  • CDMO $21.14
  • AIO N/A
  • P/E Ratio
  • CDMO N/A
  • AIO N/A
  • Revenue Growth
  • CDMO N/A
  • AIO N/A
  • 52 Week Low
  • CDMO $4.07
  • AIO $15.09
  • 52 Week High
  • CDMO $12.48
  • AIO $20.25
  • Technical
  • Relative Strength Index (RSI)
  • CDMO 67.73
  • AIO 48.53
  • Support Level
  • CDMO $11.67
  • AIO $22.00
  • Resistance Level
  • CDMO $12.30
  • AIO $23.94
  • Average True Range (ATR)
  • CDMO 0.27
  • AIO 0.49
  • MACD
  • CDMO 0.17
  • AIO -0.03
  • Stochastic Oscillator
  • CDMO 89.03
  • AIO 23.71

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

Share on Social Networks: